2,2,2-Trifluoro-N-(hydroxymethyl)acetamide, 95.0%, 500g

Ethynylferrocene, 95.0%, 1g

2-(4-FLUORO-3-(TRIFLUOROMETHYL)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95.0%, 10g

2,3-Dichloro-4-fluoronitrobenzene, 95.0%, 10g

GC capillary column ROTI®Cap-5 MS, 12 m, 0.20 mm, 0.35 µm, 1 Piece(s)

L-Phenylalanine, N-[N-[(1,1-dimethylethoxy)carbonyl]-D-leucyl]-, phenylmethyl ester, 98%, 50mg

Ethyl 6-chloro-3,4-dimethylthieno[2,3-b]pyridine-2-carboxylate, 98%, 250mg

4-(5-Bromopyridin-2-yl)morpholine, 97.0%, 5g

3-((tert-Butoxycarbonyl)amino)cyclobutanecarboxylic acid, 95.0%, 10g

3-(4-Chlorophenyl)piperazine-1-carboxylic acid tert-butyl ester, 95.0%, 1g

1-(Cyclopropylmethyl)-3-hydroxyquinazoline-2,4(1H,3H)-dione, 98%, 100mg

(R)-2-(2,5-Dimethoxyphenyl)thiazolidine-4-carboxylic acid, 95.0%, 10g

5-(3-hydroxy-3-methyl-1-butyn-1-yl)-2-furoic acid hydrate, 95.0%, 25g